Cargando…

A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence

Enteroviruses (EV) are implicated in an extensive range of clinical manifestations, such as pancreatic failure, cardiovascular disease, hepatitis, and meningoencephalitis. We recently reported on the biochemical properties of the highly conserved cysteine residue at position 38 (C38) of enteroviral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voss, Martin, Pinkert, Sandra, Kespohl, Meike, Gimber, Niclas, Klingel, Karin, Schmoranzer, Jan, Laue, Michael, Gaida, Matthias, Kloetzel, Peter-Michael, Beling, Antje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029043/ https://www.ncbi.nlm.nih.gov/pubmed/35458499 http://dx.doi.org/10.3390/v14040769

Ejemplares similares

Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model
por: Pinkert, Sandra, et al.
Publicado: (2021)

ONX 0914 Lacks Selectivity for the Cardiac Immunoproteasome in CoxsackievirusB3 Myocarditis of NMRI Mice and Promotes Virus-Mediated Tissue Damage
por: Neumaier, Hannah Louise, et al.
Publicado: (2020)

Coxsackievirus B3 Exploits the Ubiquitin-Proteasome System to Facilitate Viral Replication
por: Voss, Martin, et al.
Publicado: (2021)

Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection
por: Goetzke, Carl Christoph, et al.
Publicado: (2021)

The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
por: Althof, Nadine, et al.
Publicado: (2018)

PA28 modulates antigen processing and viral replication during coxsackievirus B3 infection
por: Respondek, Dorota, et al.
Publicado: (2017)

Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming
por: Kespohl, Meike, et al.
Publicado: (2020)

Proteasomal Protein Degradation: Adaptation of Cellular Proteolysis With Impact on Virus—and Cytokine-Mediated Damage of Heart Tissue During Myocarditis
por: Beling, Antje, et al.
Publicado: (2018)

Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression
por: Böhnke, Janik, et al.
Publicado: (2021)

Simultaneous Multicolor DNA-PAINT without Sequential Fluid Exchange Using Spectral Demixing
por: Gimber, Niclas, et al.
Publicado: (2022)

Diffusional spread and confinement of newly exocytosed synaptic vesicle proteins
por: Gimber, Niclas, et al.
Publicado: (2015)

Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
por: Fechner, Henry, et al.
Publicado: (2011)

Single-Point Mutations within the Coxsackie B Virus Receptor-Binding Site Promote Resistance against Soluble Virus Receptor Traps
por: Pinkert, Sandra, et al.
Publicado: (2020)

Role of RNA Domain Structure and Orientation in the Coxsackievirus B3 Virulence Phenotype
por: Phillips, Lydia, et al.
Publicado: (2023)

Cardiac Fibroblasts Aggravate Viral Myocarditis: Cell Specific Coxsackievirus B3 Replication
por: Lindner, Diana, et al.
Publicado: (2014)

Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis
por: Meyer, Ingmar Sören, et al.
Publicado: (2018)

Wnt3 Is Lipidated at Conserved Cysteine and Serine Residues in Zebrafish Neural Tissue
por: Dhasmana, Divya, et al.
Publicado: (2021)

Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis
por: Kaese, Sven, et al.
Publicado: (2017)

In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell(®) Cardiomyocytes
por: Kraft, Lisa, et al.
Publicado: (2021)

Arsenic 3 methyltransferase (AS3MT) automethylates on cysteine residues in vitro
por: Mersaoui, Sofiane Y., et al.
Publicado: (2022)

A SEPT1-based scaffold is required for Golgi integrity and function
por: Song, Kyungyeun, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis
por: Müller, Irene, et al.
Publicado: (2021)

The ARFRP1-dependent Golgi scaffolding protein GOPC is required for insulin secretion from pancreatic β-cells
por: Wilhelmi, Ilka, et al.
Publicado: (2020)

The role of conserved residues of chagasin in the inhibition of cysteine peptidases
por: dos Reis, Flavia C.G., et al.
Publicado: (2008)

Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor
por: Fechner, H, et al.
Publicado: (2007)

Interleukin‐12/23 deficiency differentially affects pathology in male and female Alzheimer's disease‐like mice
por: Eede, Pascale, et al.
Publicado: (2020)

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
por: Hazini, Ahmet, et al.
Publicado: (2021)

Major alteration in coxsackievirus B3 genomic RNA structure distinguishes a virulent strain from an avirulent strain
por: Prusa, Jerome, et al.
Publicado: (2014)

A cysteine protease inhibitor GC376 displays potent antiviral activity against coxsackievirus infection
por: Chen, Yongkang, et al.
Publicado: (2023)

Roles of conserved active site residues in the IscS cysteine desulfurase reaction
por: Pang, Yilin, et al.
Publicado: (2023)

Ubiquitination Is Required for Effective Replication of Coxsackievirus B3
por: Si, Xiaoning, et al.
Publicado: (2008)

Inhibition of coxsackievirus B3 by RNA interference (RNAi)
por: Kurreck, J, et al.
Publicado: (2006)

Coxsackievirus B3—Its Potential as an Oncolytic Virus
por: Geisler, Anja, et al.
Publicado: (2021)

The synaptic scaffold protein MPP2 interacts with GABA(A) receptors at the periphery of the postsynaptic density of glutamatergic synapses
por: Schmerl, Bettina, et al.
Publicado: (2022)

Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease()
por: Kim, Bo-Kyoung, et al.
Publicado: (2015)

Etymologia: Coxsackievirus
Publicado: (2012)

COXSACKIEVIRUSES (PICORNAVIRIDAE)
por: Pozzetto, Bruno, et al.
Publicado: (1999)

Coxsackievirus B3, Shandong Province, China, 1990–2010
por: Tao, Zexin, et al.
Publicado: (2012)

Coxsackievirus B3 infection reduces female mouse fertility
por: Shim, Hye Min, et al.
Publicado: (2015)

Coxsackievirus B3 targets TFEB to disrupt lysosomal function
por: Mohamud, Yasir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tp2dbi4v26mg4h3paiq4eha278